These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 12798428)

  • 1. Aldosterone receptor blockade improves left ventricular remodeling and increases ventricular fibrillation threshold in experimental heart failure.
    Cittadini A; Monti MG; Isgaard J; Casaburi C; Strömer H; Di Gianni A; Serpico R; Saldamarco L; Vanasia M; Saccà L
    Cardiovasc Res; 2003 Jun; 58(3):555-64. PubMed ID: 12798428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of canrenone on myocardial reactive fibrosis in a rat model of postinfarction heart failure.
    Cittadini A; Casaburi C; Monti MG; Di Gianni A; Serpico R; Scherillo G; Saldamarco L; Vanasia M; Saccà L
    Cardiovasc Drugs Ther; 2002 May; 16(3):195-201. PubMed ID: 12374896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of losartan, ramipril and their combination on left ventricular remodeling and function in spontaneous hypertensive rats].
    Xu R; Zhang Y; Zhang M; Li XC; Cai H; Chen WQ; Zhu H; Ge ZM; Zhang W
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3199-204. PubMed ID: 16405840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction.
    Fraccarollo D; Galuppo P; Hildemann S; Christ M; Ertl G; Bauersachs J
    J Am Coll Cardiol; 2003 Nov; 42(9):1666-73. PubMed ID: 14607457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline characteristics of patients recruited in the AREA IN-CHF study (Antiremodelling Effect of Aldosterone Receptors Blockade with Canrenone in Mild Chronic Heart Failure).
    Boccanelli A; Cacciatore G; Mureddu GF; de Simone G; Clemenza F; De Maria R; Di Lenarda A; Gavazzi A; Latini R; Masson S; Porcu M; Vanasia M; Gonzini L; Maggioni AP
    J Cardiovasc Med (Hagerstown); 2007 Sep; 8(9):683-91. PubMed ID: 17700397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction.
    Fraccarollo D; Galuppo P; Schmidt I; Ertl G; Bauersachs J
    Cardiovasc Res; 2005 Jul; 67(1):97-105. PubMed ID: 15949473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ramipril and furosemide treatment on interstitial remodeling in post-infarction heart failure rat hearts.
    Seeland U; Kouchi I; Zolk O; Itter G; Linz W; Böhm M
    J Mol Cell Cardiol; 2002 Feb; 34(2):151-63. PubMed ID: 11851355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of diuretic treatment on cardiac and circulating RAS in chronic heart failure post-myocardial infarction in rats.
    Seeland U; Kouchi I; Zolk O; Jockenhövel F; Itter G; Linz W; Böhm M
    Eur J Heart Fail; 2003 Jun; 5(3):241-6. PubMed ID: 12798820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined effects of ramipril and angiotensin II receptor blocker TCV116 on rat congestive heart failure after myocardial infarction.
    Tao ZW; Huang YW; Xia Q; Xu QW
    Chin Med J (Engl); 2005 Jan; 118(2):146-54. PubMed ID: 15667801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of beta-blockers on cardiac function and calcium handling protein in postinfarction heart failure rats.
    Sun YL; Hu SJ; Wang LH; Hu Y; Zhou JY
    Chest; 2005 Sep; 128(3):1812-21. PubMed ID: 16162791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with ramipril improves systolic function even in patients with mild systolic dysfunction and symptoms of heart failure after acute myocardial infarction.
    Kongstad-Rasmussen O; Blomstrand P; Broqvist M; Dahlström U; Wranne B
    Clin Cardiol; 1998 Nov; 21(11):807-11. PubMed ID: 9825192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure.
    Suzuki G; Morita H; Mishima T; Sharov VG; Todor A; Tanhehco EJ; Rudolph AE; McMahon EG; Goldstein S; Sabbah HN
    Circulation; 2002 Dec; 106(23):2967-72. PubMed ID: 12460880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldosterone antagonist improves diastolic function in essential hypertension.
    Grandi AM; Imperiale D; Santillo R; Barlocco E; Bertolini A; Guasti L; Venco A
    Hypertension; 2002 Nov; 40(5):647-52. PubMed ID: 12411457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial natriuretic peptide helps prevent late remodeling after left ventricular aneurysm repair.
    Tsuneyoshi H; Nishina T; Nomoto T; Kanemitsu H; Kawakami R; Unimonh O; Nishimura K; Komeda M
    Circulation; 2004 Sep; 110(11 Suppl 1):II174-9. PubMed ID: 15364859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction.
    Udelson JE; Feldman AM; Greenberg B; Pitt B; Mukherjee R; Solomon HA; Konstam MA
    Circ Heart Fail; 2010 May; 3(3):347-53. PubMed ID: 20299607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of ramipril on left ventricular end-diastolic and end-systolic volume indexes after uncomplicated invasive revascularization are associated with a reduction in cardiac events in patients with moderately impaired left ventricular function and no clinical heart failure.
    Kjøller-Hansen L; Steffensen R; Grande P
    J Am Coll Cardiol; 2001 Apr; 37(5):1214-20. PubMed ID: 11300425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
    Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
    Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodelling in rats after myocardial infarction.
    Huang BS; White RA; Ahmad M; Tan J; Jeng AY; Leenen FH
    Cardiovasc Res; 2009 Feb; 81(3):574-81. PubMed ID: 18689429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of eplerenone on transcriptional factors and mRNA expression related to cardiac remodelling after myocardial infarction.
    Enomoto S; Yoshiyama M; Omura T; Matsumoto R; Kusuyama T; Kim S; Izumi Y; Akioka K; Iwao H; Takeuchi K; Yoshikawa J
    Heart; 2005 Dec; 91(12):1595-600. PubMed ID: 15797934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.